Copyright © 2021. Inderes Oyj. All rights reserved.

CellaVision invites institutional investors, financial analysts and media to join its Capital Markets Day on June 16, 2022.

During the event, CellaVision’s executive management will present the next exciting phase of our strategic vision: The Power of Focus – Enhancing the Future of Microscopy.

Join us for an update on our operational priorities and focused insights on new growth opportunities over the next five years.

The presentations will be followed by a Q&A session. All presentation material will be available on the company’s website after the event.

Date: June 16, 2022
Time: 14.00-17.30 CEST
Location: CellaVision, Mobilvägen 12, 223 62 Lund, Sweden

To register your attendance, please send an email to [email protected] by June 10, 2022, at the latest, stating your full name, title and company.

For our Q&A session at the event, you are welcome to send any questions ahead of
time to Adele Horn, Corporate Communications & Investor Relations, at
[email protected]

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China and Japan. The company derives the majority of its revenue from the sale of analyzers.